Intelligence Β· INN Directory
Pharmaceutical Drugs
Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.
- Drugs indexed
- 4,797
- Companies
- 1,769
- Pipeline programs
- 20,548
Quick answer
NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse AβZ for competitive intelligence and medical affairs reference.
-
sunitinib
ARX-SUNITINIB Pfizer Australia Pty Ltd
L01EX01 -
sunitinib malate
SUTENT Teva Pharma GmbH
-
sunvozertinib
ZEGFROVY
-
superoxide
-
supportive
-
suprofen
PROFENAL
-
surfactant
-
surufatinib
SEVSURY
L01EX01 -
susoctocog alfa
OBIZUR
B02 -
suspension
-
sutilains
TRAVASE
-
sutimlimab
ENJAYMO
L04AJ04 -
sutimlimab-jome
ENJAYMO
-
suvorexant
SUVOREXANT
-
suzetrigine
JOURNAVX Vertex Pharmaceuticals (Australia) Pty.
-
syrup
NULL
-
t-cell
-
tabelecleucel
EBVALLO
-
tablet
-
tablets
-
tacrine hydrochloride
COGNEX
-
tacrolimus
ADVAGRAF XL Alphapharm Pty Ltd
D11AH01 -
tadalafil
ADCIRCA Alphapharm Pty Ltd
G04BE08 -
taf
Frequently asked questions
What is the NovaPharmaNews drugs directory?
It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.
Where does drug approval data come from?
Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.
How do I find a drug by brand name?
Use the search box on this page β it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.
Data attribution and licensing: Data sources